![Dr. Johanna Maukonen](https://evessio.s3.amazonaws.com/customer/862abfb6-803f-40c2-afb4-fc3e7c465bcd/event/bba71e9d-3cdc-4fe9-bc4d-6f9befb52c46/media/73a43b0e-profile_Speaker_Image_-_Johanna_Maukonen_Large.png)
Dr. Johanna Maukonen
Director, Global Clinical Innovation & Translation
IFF
Johanna focuses on developing scientifically sound translation of customer and market needs to R&D strategy and projects, being a key link for Health R&D to customers and external scientific communities. Between 2017-2022, she led DuPont/IFF Global Health and Nutrition Science group, which conducts and coordinates in vitro, pre-clinical and clinical studies on IFF’s ingredients. Before joining IFF, Johanna spent over 20 years at VTT Technical Research Centre. She has extensive R&D experience in understanding the gut microbiota and its impact on health, especially on the influence of probiotics, nutrition and fibers. She has D.Sc.(Tech) on characterization of predominant human fecal microbiota.